ARTICLE | Company News
Merck infectious news
January 2, 2012 8:00 AM UTC
Merck reduced the price of its HIV drug Isentress raltegravir for state AIDS Drug Assistance Programs (ADAPs). The pharma has not disclosed the reduction, which will remain in effect until Dec. 31, 2...